APLS
Price
$64.82
Change
+$0.95 (+1.49%)
Updated
Dec 5, 6:59 PM EST
83 days until earnings call
CYTK
Price
$32.56
Change
-$1.33 (-3.92%)
Updated
Dec 5, 6:59 PM EST
79 days until earnings call
Ad is loading...

Analysis and predictions APLS vs CYTK

Header iconAPLS vs CYTK Comparison
Open Charts APLS vs CYTKBanner chart's image
Apellis Pharmaceuticals
Price$64.82
Change+$0.95 (+1.49%)
Volume$1.53M
CapitalizationN/A
Cytokinetics
Price$32.56
Change-$1.33 (-3.92%)
Volume$668.87K
CapitalizationN/A
View a ticker or compare two or three
APLS vs CYTK Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
APLS vs. CYTK commentary
Dec 06, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and CYTK is a StrongBuy.

COMPARISON
Comparison
Dec 06, 2023
Stock price -- (APLS: $64.86 vs. CYTK: $32.54)
Brand notoriety: APLS and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 114% vs. CYTK: 69%
Market capitalization -- APLS: $5.72B vs. CYTK: $3.12B
APLS [@Biotechnology] is valued at $5.72B. CYTK’s [@Biotechnology] market capitalization is $3.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 2 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 2 green, 3 red.
According to our system of comparison, both APLS and CYTK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 4 TA indicator(s) are bullish while CYTK’s TA Score has 5 bullish TA indicator(s).

  • APLS’s TA Score: 4 bullish, 4 bearish.
  • CYTK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а +37.53% price change this week, while CYTK (@Biotechnology) price change was +4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.28%. For the same industry, the average monthly price growth was +25.03%, and the average quarterly price growth was +26.76%.

Reported Earning Dates

APLS is expected to report earnings on Feb 26, 2024.

CYTK is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+12.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for APLS with price predictions.
OPEN
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
APLS($5.72B) has a higher market cap than CYTK($3.12B). APLS YTD gains are higher at: 25.353 vs. CYTK (-28.939). CYTK has higher annual earnings (EBITDA): -462.64M vs. APLS (-575.25M). CYTK has more cash in the bank: 539M vs. APLS (452M). APLS has less debt than CYTK: APLS (110M) vs CYTK (748M). APLS has higher revenues than CYTK: APLS (273M) vs CYTK (7.82M).
APLSCYTKAPLS / CYTK
Capitalization5.72B3.12B183%
EBITDA-575.25M-462.64M124%
Gain YTD25.353-28.939-88%
P/E RatioN/AN/A-
Revenue273M7.82M3,493%
Total Cash452M539M84%
Total Debt110M748M15%
FUNDAMENTALS RATINGS
APLS vs CYTK: Fundamental Ratings
APLS
CYTK
OUTLOOK RATING
1..100
3217
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
3627
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3777
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APLS's Valuation (82) in the Medical Distributors industry is in the same range as CYTK (100) in the Biotechnology industry. This means that APLS’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (27) in the Biotechnology industry is in the same range as APLS (36) in the Medical Distributors industry. This means that CYTK’s stock grew similarly to APLS’s over the last 12 months.

APLS's SMR Rating (99) in the Medical Distributors industry is in the same range as CYTK (100) in the Biotechnology industry. This means that APLS’s stock grew similarly to CYTK’s over the last 12 months.

APLS's Price Growth Rating (37) in the Medical Distributors industry is somewhat better than the same rating for CYTK (77) in the Biotechnology industry. This means that APLS’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for APLS (100) in the Medical Distributors industry. This means that CYTK’s stock grew significantly faster than APLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLSCYTK
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KWT29.970.15
+0.50%
iShares® MSCI Kuwait ETF
HYB6.860.01
+0.15%
New America High Income Fund
STPZ50.680.03
+0.06%
PIMCO 1-5 Year US TIPS Index ETF
DWCR28.20N/A
N/A
Arrow DWA Tactical International ETF
EFAV67.47-0.16
-0.24%
iShares MSCI EAFE Min Vol Factor ETF

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with QNRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then QNRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+1.46%
QNRX - APLS
48%
Loosely correlated
-0.42%
MDGL - APLS
44%
Loosely correlated
+5.91%
KRYS - APLS
42%
Loosely correlated
-0.84%
AXON - APLS
33%
Loosely correlated
-1.96%
ASND - APLS
33%
Loosely correlated
+0.55%
More